Bharat Parenterals Gains 9.13%: Key Drivers Behind the Weekly Surge
2026-11-21 13:01:12Key Events This Week 16 Nov: Stock opens strong at Rs.2,217 (+4.27%) 18 Nov: New 52-week and all-time high reached (Rs.2,441.25 intraday) 19 Nov: Profit-taking leads to a 1.91% decline 20 Nov: Week closes at Rs.2,320.40 (-3.10%) Week OpenRs.2,126.20 Week CloseRs.2,320.40<div class="stat-c...
Read More
Bharat Parenterals Ltd Hits New 52-Week High of Rs 2300 on Back of Strong Technical Signals
2026-11-18 10:44:37Surging past its previous peaks, Bharat Parenterals Ltd touched an all-time high of Rs 2300 on 18 Nov 2026, marking a remarkable 102.21% gain over the past year. This milestone comes amid a backdrop of robust technical momentum that has propelled the stock well above its key moving averages, signalling sustained strength despite a broadly cautious market environment.
Read More
Bharat Parenterals Ltd Surges to All-Time High of Rs 2,295 Amid Strong Momentum
2026-11-18 10:23:35Extending its remarkable rally, Bharat Parenterals Ltd touched a fresh all-time high of Rs 2,295.20 on 18 Nov 2026, marking a significant milestone in its market journey as it outpaced the Sensex by a wide margin over multiple timeframes.
Read More
Bharat Parenterals Ltd is Rated Hold
2026-11-14 10:10:04Bharat Parenterals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 November 2026, providing investors with an up-to-date view of the company’s performance and prospects.
Read MoreBharat Parenterals Surges 21.89%: 3 Key Events Fueling the Rally
2026-10-31 13:02:35Key Events This Week Oct 26: Stock jumps 8.19% to Rs.1,799.00 on strong volume Oct 27: Gains continue with 4.74% rise to Rs.1,884.30 Oct 30: Hits new 52-week and all-time high of Rs.2,292.15; upper circuit triggered Oct 30: Week closes at Rs.2,026.65, up 21.89% for the week Week OpenRs.1,662.75 Week Close<div class="s...
Read More
Bharat Parenterals Ltd Locks at Upper Circuit With 13.1% Gain — Buyers Queue, Sellers Absent
2026-10-30 10:00:39At Rs 2,295.10, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bharat Parenterals Ltd locked at its upper circuit of 13.09% on 30 Oct 2026, with buyers queuing and no sellers willing to part with shares.
Read More
Bharat Parenterals Ltd Hits All-Time High of Rs 2292.15 as Momentum Builds Across Timeframes
2026-10-30 09:35:58After opening with an 18.52% gap up, Bharat Parenterals Ltd surged further to touch a fresh all-time high of Rs 2292.15 on 30 Oct 2026, outperforming its sector by 14.31% and the Sensex by a wide margin. This milestone caps a remarkable rally that has seen the stock rise 77.22% over the past year, defying a broader market that has declined nearly 12% in the same period.
Read More
Bharat Parenterals Ltd is Rated Sell
2026-10-23 10:10:46Bharat Parenterals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 October 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More
Bharat Parenterals Ltd is Rated Sell by MarketsMOJO
2026-10-12 10:11:05Bharat Parenterals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 12 October 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read MoreClarification On Price Movement
20-Nov-2026 | Source : BSEClarification w.r.t. the query raised by BSE for clarification on Price Movement in our Security.
Clarification sought from Bharat Parenterals Ltd
19-Nov-2026 | Source : BSEThe Exchange has sought clarification from Bharat Parenterals Ltd on November 19 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.
The reply is awaited.
Announcement under Regulation 30 (LODR)-Press Release / Media Release
05-Nov-2026 | Source : BSEIntimation for receipt of Establishment Inspection Report from US FDA by Innoxel Lifesciences Pvt Ltd. a subsidiary company of Bharat Parenterals Limited.
Corporate Actions
No Upcoming Board Meetings
Bharat Parenterals Ltd has declared 10% dividend, ex-date: 11 Sep 26
No Splits history available
No Bonus history available
No Rights history available